US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place

GlobalData's "US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place" report is an essential source of data and analysis on the US small joint implants market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - ankle replacement, digits replacement, elbow replacement and wrist replacement. The report identifies the key trends shaping and driving the dynamism in the US small joint implants market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the US small joint implants market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Increased Investments Boosts The Medical Equipment Market In Q3 2009

GlobalData's "Medical Equipment Quarterly Deals Analysis Q3 2009" report is an essential source of data and trend analysis on the Mergers and Acquisitions (M&A) and financings in the medical equipment market. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered in the medical equipment industry in Q3 2009. The report portrays detailed comparative data on the number of deals and their value in the last five quarters subdivided by deal types, segments, and geographies. Additionally, the report provides information on the top private equity, venture capital, and advisory firms in the medical equipment industry.
Data presented in this report is derived from GlobalData's proprietary in-house Medical eTrack deals database and primary and secondary research.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

India Ultrasound Systems Market: Strategic Market Analysis and Insight

GlobalData's "India Ultrasound Systems Market: Strategic Market Analysis and Insight" report is an essential source of data and analysis on the India Ultrasound Systems market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - B/W Ultrasound System and Color Doppler Ultrasound System. The report identifies the key trends shaping and driving the dynamism in the India Ultrasound Systems market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the India Ultrasound Systems market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Pharmaceutical Company Outlook to 2014

PharmaVitae universe Rx sales are forecast to expand at a 2008-14 CAGR of 1.2%, down 9.3 percentage points from 2002-08. The underlying cause of this falling rate is the much-discussed genericization of small molecule products. However, not all sectors are equally exposed, prompting a shake-up of the industry and an increasing pursuit of cost savings to sustain operating profit growth rates.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Cost containment and M&A shape the global generics industry

This report analyses both quantitatively and qualitatively the unbranded generics industry, the Top 10 generics companies by unbranded generics sales, the Top five therapy areas and the major North American, European, Asia Pacific and Latin American markets.

Generics Overview in the Seven Major Markets

Increasing generics volume uptake will provide much needed cost-savings in the less mature markets of France, Italy, Spain, and Japan, and requires regulators to incorporate effective utilization incentives for key stakeholders. While volume will grow in the US, Germany, and the UK, regulators are increasingly looking to capture value from generics by pushing down price and speeding market access.

Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment

GlobalData's "Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment" report is an essential source of data and analysis on the Europe PACS market. The report provides market landscape, competitive landscape and market trends information on the Europe PACS market. The report identifies the key trends shaping and driving the dynamism in the Europe PACS market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the Europe PACS market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand

GlobalData's "US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand" report is an essential source of data and analysis on the US surgical sutures market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - absorbable sutures and non absorbable sutures. The report identifies the key trends shaping and driving the dynamism in the US surgical sutures market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the US surgical sutures market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report! 

Sanofi-Aventis: PharmaVitae Profile

This analysis examines the historical and forecast performance for Sanofi-Aventis in the pharmaceutical sector.

The Evolving Pharma M&A Landscape: Emerging trends and predicted post-blockbuster targets

The report identifies the factors responsible for growing pressure on leading pharmaceutical businesses and strategic responses being pursued by the industry. It includes a critical appraisal of mega-mergers triggered by similar factors in the past, and an analysis of the two mega-mergers that have been announced since the beginning of 2009.

Colorectal Cancer - Growing trend towards personalized medicine

CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for CRC, 4 of which are in late-phase development. Collectively, they are forecast to achieve sales of $1,398m by 2018.

New Multi-Marketing Channel Strategies

The future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited.

Generic Strategies in Emerging Markets

The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targets for firms aiming to expand their foothold, initially as a generics player, but also providing a foundation for subsequent brand penetration.

Mapping the Healthcare Landscape: Bringing pharmaceuticals into focus

Courtesy of the patent cliff, the pharmaceutical industry is set for a dramatic slow down in revenue growth from 2011. Industry players are therefore looking to implement strategies which will cushion them against the anticipated revenue short-fall, with diversification away from pharmaceuticals into other healthcare sectors one avenue under consideration.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan

Over the past decade, vaccines have resurfaced as an attractive commercial proposition for Pharma. The developed world has been the initial focus of vaccine makers due to the better healthcare infrastructure and higher price levels. However, facing increasingly saturated markets in the West, companies are looking to expand into new geographies, such as Asia's emerging markets.

Influenza Vaccines and Antivirals - The pandemic's long-term impact

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges.

The Diabetes Market Outlook to 2011

The Diabetes Market Outlook to 2011 provides in-depth insights into new product launches, upcoming patent expiries and on-going clinical trials in order to predict changes in global market dynamics. Key R&D trends are analyzed and pipeline compounds of the top players are evaluated, enabling you to strengthen your position in the diabetes market and anticipate future product success.

Molecular Targeted Cancer Therapies - Leading companies will hold onto competitive advantage in high growth market

Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent expiries, it is unsurprising that the major oncology companies have shifted their focus towards the molecular targeted cancer therapies market.